Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection among Kidney Transplant Recipients: A Large Single-Center Experience
Table 2
Outcomes.
Characteristics
All
Hospitalized
Non-hospitalized
979
381
598
Respiratory symptoms for admission (%)
285 (29)
285 (75)
N/A
Intensive care unit admission (%)
88 (9)
88 (23)
NA
Serum creatinine at the time of SARS-CoV-2 infection (mg/dl)
2.01 ± 1.80
2.25 ± 1.56
1.59 ± 0.61
<0.001
Serum eGFR at the time of SARS-CoV-2 infection (mL/min/1.73 m2)
43.4 ± 20.8
39.6 ± 20.8
50.2 ± 18.9
<0.001
Serum creatinine 1 month post SARS-CoV-2 infection (mg/dl)
1.53 ± 0.83
1.70 ± 1.05
1.43 ± 0.64
<0.001
Serum eGFR 1 month post SARS-CoV-2 infection (mL/min/1.73 m2)
54.6 ± 22.8
49.8 ± 23.0
57.3 ± 22.3
<0.001
Serum creatinine 6 months post SARS-CoV-2 infection (mg/dl)
1.51 ± 0.74
1.69 ± 0.92
1.43 ± 0.63
<0.001
Serum eGFR 6 months post SARS-CoV-2 infection (mL/min/1.73 m2)
55.5 ± 22.2
49.9 ± 22.0
58.0 ± 21.8
<0.001
Serum creatinine 1 year post SARS-CoV-2 infection (mg/dl)
1.52 ± 0.88
1.74 ± 1.14
1.42 ± 0.71
<0.001
Serum eGFR 1 year post SARS-CoV-2 infection (mL/min/1.73 m2)
56.6 ± 22.8
49.9 ± 22.1
59.4 ± 22.5
<0.001
Serum creatinine at last follow-up (mg/dl)
1.47 ± 0.71
1.63 ± 0.89
1.41 ± 0.62
<0.001
Serum eGFR at last follow-up (mL/min/1.73 m2)
57.8 ± 22.6
52.9 ± 22.5
59.6 ± 22.5
<0.001
Uncensored graft failure at last follow-up (%)
205 (21)
170 (45)
35 (6)
<0.001
Death at last follow-up (%)
156 (16)
141 (37)
15 (3)
<0.001
Death related to COVID-19 (%)
119 (12)
116 (30)
3 (1)
<0.001
Bold values signify statistically significant with p value less than 0.05.
